Michael Wright

University of Tennessee Health Science Center

Biochemistry, Genetics and Molecular BiologyNeuroscienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy”.

Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy

Journal of Clinical Oncology(2025)10.1200/jco-24-01861

N/A

0.241DataRank · unranked

4 citations

Shahrad R. Rassekh, Austin L. Brown, Qi Nie, Adam J. Esbenshade, Kristin R. Knight +11 more

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

The Lancet Child & Adolescent Health(2021)10.1016/s2352-4642(21)00020-1

N/A

0DataRank · unranked

89 citations

Chunqiao Luo, Joshua Millstein, Kristin R. Knight, Shahrad R. Rassekh, Beth Brooks +8 more

Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.02.050

N/A

0DataRank · unranked

14 citations

Kenneth Wong, Victoria Mena, Kevin Sianto, Michael Wright, Arthur J. Olch +2 more